PD Site map

Each line in the hierarchical Site Map below is in two parts:

The link text as it usually appears in the text and

The link to the page or subpage with its full Wikiversity name.

The User Guide for this Wikiversity learning project is at PD_Wiki_User_Guide

The Science Behind Parkinson's - Portal:The_Science_Behind_Parkinson's

> Project Development - Portal:The_Science_Behind_Parkinson's/Project_Development

> The six purposes of Section 1 - Portal:The_Science_Behind_Parkinson's/Section 1/more

> Section 1: Progress and Prospects in Parkinson's Research - Progress_and_Prospects_in_Parkinson's_Research

> > - Magazine Section - PD_Magazine_Section

> Getting the ball rolling - PD_Magazine_Section/Getting_the_ball_rolling

> Hot Topics - PD_Hot_Topics

> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D

> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein

> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents

> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease

> Induced Pluripotent Stem Cells - Modelling_PD/iPSC

> Genome-Wide Association Studies - PD_Inheritance/GWAS

> Getting Drugs from Lab to Clinic - PD_Research_to_clinic

> > - Researching Parkinson's - Researching_Parkinson's

> Modelling Parkinson's - Modelling_PD

> Animal Models - Modelling_PD/Animal_Models

> Rotenone Model - Modelling_PD/Rotenone PD Model

> Induced Pluripotent Stem Cells - Modelling_PD/iPSC

> Hot Topics - PD_Hot_Topics

> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D

> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein

> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents

> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease

> Induced Pluripotent Stem Cells - Modelling_PD/iPSC

> Genome-Wide Association Studies - PD_Inheritance/GWAS

> Getting Drugs from Lab to Clinic - PD_Research_to_clinic

> > - Causes - PD_Causes

> Inheritance - PD_Inheritance

> SNCA - PD_Inheritance/SNCA

> LRRK2 - PD_Inheritance/LRRK2

> MAPT - PD_Inheritance/MAPT

> GBA - PD_Inheritance/GBA

> HLA - PD_Inheritance/HLA

> Trauma - Trauma as PD Cause

> Infection - Infection_as_PD_cause

> Melanoma - Infection_as_PD_cause/Melanoma

> Whooping cough - Infection_as_PD_cause/Whooping cough

> Helicobacter - Infection_as_PD_cause/Helicobacter_pylorii

> Deficiencies

> Blood - Deficiencies_as_PD_cause/Blood

> Glutathione - Deficiencies_as_PD_cause/Glutathione

> Melatonin - Deficiencies_as_PD_cause/Melatonin

> Norepinephrine - Deficiencies_as_PD_cause/Norepinephrine

> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D

> Zinc - Deficiencies_as_PD_cause/Zinc

> Toxins - Toxins_as_PD_cause

> Cadmium - Toxins_as_PD_cause/Cadmium

> Copper - Toxins_as_PD_cause/Copper

> Dieldrin - Toxins_as_PD_cause/Dieldrin

> Manganese - Toxins_as_PD_cause/Manganese

> Maneb - Toxins_as_PD_cause/Maneb

> Mercury - Toxins_as_PD_cause/Mercury

> MPTP - Toxins_as_PD_cause/MPTP

> n-Hexane - Toxins_as_PD_cause/n-Hexane

> Paraquat - Toxins_as_PD_cause/Paraquat

> Rotenone - Toxins_as_PD_cause/Rotenone

> Toluene - Toxins_as_PD_cause/Toluene

> Trichloroethylene - Toxins_as_PD_cause/Trichloroethylene

> Ziram - Toxins_as_PD_cause/Ziram

> > - Pathogenesis - Parkinson's_Pathogenesis

> Current Parkinson's Paradigm - Current_Parkinson's_Paradigm

> Working Hypothesis - Current_Parkinson's_Paradigm/Working_Hypothesis

> Emerging Hypotheses - Current_Parkinson's_Paradigm/Emerging_Hypotheses

> Oxidative Stress - Current_Parkinson's_Paradigm/Oxidative_Stress

> Role of alpha-synuclein - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein

> > - Therapy - PD_Therapy

> Transplantation - Transplantation_for_PD

> Symptomatic Relief - Symptomatic Relief_for_PD

> Bradykinesia - Symptomatic Relief_for_PD/Bradykinesia

> Dyskinesia - Symptomatic Relief_for_PD/Dyskinesia

> Festination - Symptomatic Relief_for_PD/Festination

> Freezing - Symptomatic Relief_for_PD/Akinesia

> Non-motor symptoms - Symptomatic Relief_for_PD/Non-Motor

> Tremor - Symptomatic Relief_for_PD/Tremor

> Exercise - Exercise_for_PD

> Effect on symptoms - Exercise_for_PD/Effect_on_Symptoms ::::> Neuroprotective effects - Exercise_for_PD/Neuroprotective_effects

> Neuroprotection - PD_Neuroprotection

> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents

> Caffeine - PD_Neuroprotection/Caffeine

> Celastrol - PD_Neuroprotection/Celastrol

> Co-enzyme Q10 - PD_Neuroprotection/Co-Enzyme Q10

> Creatine - PD_Neuroprotection/Creatine

> DHA - PD_Neuroprotection/DHA

> Exendin-4 (EX-4) - PD_Neuroprotection/Exendin-4 (EX-4)

> GDNF - PD_Neuroprotection/GDNF

> Glutathione (GSH) - PD_Neuroprotection/Glutathione (GSH)

> GM1 - PD_Neuroprotection/GM1

> Isradipine - PD_Neuroprotection/Isradipine

> Melatonin - PD_Neuroprotection/Melatonin

> Mirapex - PD_Neuroprotection/Mirapex

> Minocycline - PD_Neuroprotection/Minocycline

> Nicotine - PD_Neuroprotection/Nicotine

> NSAIDs - PD_Neuroprotection/NSAIDs

> Phenylbutyrate - PD_Neuroprotection/Phenylbutyrate

> Phytic Acid - PD_Neuroprotection/Phytic Acid

> Quinoxaline - PD_Neuroprotection/Quinoxaline

> Rasagiline - PD_Neuroprotection/Rasagiline

> Riboflavin - PD_Neuroprotection/Riboflavin

> Statins - PD_Neuroprotection/Statins

> Tolcapone - PD_Neuroprotection/Tolcapone

> Urate & Uric Acid - PD_Neuroprotection/Urate & Uric Acid

> Vitamin D - PD_Neuroprotection/Vitamin D

> Vitamin E - PD_Neuroprotection/Vitamin E

> From Lab to Clinic - PD_Research_to_clinic

> Clinical trials and the route to market - PD_Research_to_clinic/The route to market

> > - Monitoring Disease - Monitoring_Parkinson's_Disease

> Biomarkers - Biomarkers_for_PD

> Measurement of Disease Progression - Measurement_of_Parkinson's_Disease Progression

> > - Atypical parkinsonism - Atypical_parkinsonism

> MSA - Multiple_System_Atrophy

> PSP - Progressive_Supranuclear_Palsy

> DLB - Dementia_with_Lewy_Bodies

> ET - Essential Tremor

> CBD - Corticobasal_Degeneration_(CBD)

> Section 2: Introduction to Parkinson's Science - Introduction_to_Parkinson's_Science

> Site Map for Section 2 - Introduction_to_Parkinson's_Science/Site_Map